Skip to content
Aperlena

TED - Tenders Electronic Daily (Publications Office of the EU) verified 4 hours ago Prior information notice

Finland - Medical equipments, pharmaceuticals and personal care products - Request for information: Radioactive seeds (I-125) and plaques (Ru-106) used in eye brachytherapy

Upcoming Finland Medical equipment & pharmaceuticals

Buyer HUS Group

Key facts

Published
  1. Published

TED - Tenders Electronic Daily (Publications Office of the EU) does not publish a closing date for this notice. See the official notice

View the official notice Watch this tender

We email you if the deadline moves or a correction is published. Free. Log in

Summary

Machine-generated summary

HUS, the hospital district in Finland, has launched a market consultation to prepare a future procurement of radioactive products used in eye brachytherapy for treating epibulbar and intraocular tumors. The planned procurement covers Iodine-125 (I-125) brachytherapy seeds with an activity of approximately 500-600 MBq per seed, Ruthenium-106 (Ru-106) eye plaques and applicators, and accessories for plaque positioning and treatment planning, such as dummy plaques and plaque templates. Suppliers are asked to describe their relevant product portfolio, typical delivery times, and available options for sterilization, transport, storage and quality assurance, as well as treatment planning systems with software, training and user support. Responses, which may include brochures, should be sent by email by 23.10.2026 at 12.00 (UTC +3) to kilpailutus.tiimi@hus.fi, quoting 'Request for information: HUS 277-2026 Radioactive seeds and plaques' in the title or message field.

Description

With this request for information, HUS launches a market consultation to prepare a procurement. The aim of this prior information notice is to find suppliers operating in this field of business, get information of the solutions available in the market, and inform our plans and requirements for the forthcoming procurement. SUBJECT OF PROCUREMENT The subject of procurement is radioactive products used in brachytherapy for treatment of epibulbar and intraocular tumors. The procurement includes Iodine-125 (I-125) brachytherapy seeds (activity approx. 500-600 MBq per seed), Ruthenium-106 (Ru-106) eye plaques/applicators, and accessories used in plaque positioning and treatment planning (e.g. dummy plaques/plaque templates). The respondents are asked to provide information on the following questions: - Which I-125 brachytherapy seeds, Ru-106 eye plaques/applicators, and related accessories are included in your current product portfolio? - What are typical delivery times for these products? - Please indicate available options related to accessories/equipment for plaque sterilization, transport, and storage; quality assurance (measurements carried out locally for wipe test samples, depth dose curves, etc.); treatment planning systems (software, training, user support, etc.), if any. - Any other comments, observations, or information that may be relevant for the preparation of the procurement. RESPONSES TO THE REQUEST FOR INFORMATION The response to this request for information should include description to the above questions. Within the answer feel free to attach any brochures available of the products/services. Responses are requested to be submitted by 23.10.2026 at 12.00 (UTC +3) at the latest, to the email address kilpailutus.tiimi@hus.fi The title or message field of the e-mail should mention: Request for information: HUS 277-2026 Radioactive seeds and plaques. INFORMATION FOR THE PROCEDURE This notice is not a call for tenders. HUS may specify the subject of the procurement in a subsequent contract notice. The requirements for a subsequent procurement and invitation to tender will be determined based on the needs of the contracting entity, with the aim of considering the information obtained in the market survey. This notice provides the information currently held by the contracting entity on the procurement to operators on the market. The procurement is in the planning stage and the plans, with their schedules and information, can still be specified and changed. The request for information does not oblige the procurement unit to carry out the actual procurement, but the decision to initiate a possible procurement process is made separately. Neither the request for information nor its replies are binding on either party. Responding to a request for information does not affect the position of the tenderer in the forthcoming tender. The costs associated with responding to a request for information are borne by the respondent, and HUS does not pay compensation for responding to a request for information or participating the procurement procedure.

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Report an error in this notice

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 4 hours ago

HUS Group

Finland

notices in the register
51
awards
13
awarded in total
€4.8M

Who wins its contracts

of its calls state an estimated value
0%

One dot per award, on the day it was signed, sized by its value. A ring is an award with no published value.

Who usually wins this buyer's contracts in this sector

Company Wins Total awarded Last win
MoMedico ApS; BXTAccelyon Ltd 1 €1.1M Sep 2026
Triolab Oy 1 €700,000 Dec 2025
Bio-Rad Finland Oy; VWR International Oy; BioNordika Oy 1 €690,500 Feb 2026
Haemochrom Diagnostica GmbH 1 €600,000 Oct 2025
Reagena Oy 1 €535,450 Feb 2026

Based on 6 awards with a linked company profile over the last 5 years.

1 open tender right now

Market context

open now in Medical equipment & pharmaceuticals
11,120
median open notice
€142,857

Who wins in this market

Many suppliers

Finland · Medical equipment & pharmaceuticals

different companies won awards here
410
of the awards went to the three most frequent winners
7%
buyers awarded contracts here
161

Based on 605 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)
3.0
of those lots received a single tender
17%
of the awards went to companies based in another country
9%
of the tenders came from another country
2%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

Similar tenders

Open now

Awarded before

Never miss a tender like this

1,065 new notices in Medical equipment & pharmaceuticals in Finland in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
o
Open the result in a new tab
x
Set this result aside
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Index

Close
Log in

Language